SACCENTI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 2.789
EU - Europa 990
AS - Asia 608
OC - Oceania 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.392
Nazione #
US - Stati Uniti d'America 2.787
CN - Cina 328
IT - Italia 251
PL - Polonia 212
DE - Germania 135
TR - Turchia 131
UA - Ucraina 108
GB - Regno Unito 101
SG - Singapore 91
SE - Svezia 71
BE - Belgio 34
ID - Indonesia 29
FI - Finlandia 28
FR - Francia 16
CZ - Repubblica Ceca 13
RU - Federazione Russa 10
VN - Vietnam 9
HK - Hong Kong 6
IE - Irlanda 4
IN - India 4
AU - Australia 3
IR - Iran 3
KR - Corea 3
NL - Olanda 3
CA - Canada 2
JP - Giappone 2
AT - Austria 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
MY - Malesia 1
NO - Norvegia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 4.392
Città #
Woodbridge 405
Fairfield 387
Ann Arbor 245
Chandler 238
Warsaw 212
Houston 176
Seattle 164
Ashburn 157
Ferrara 139
Jacksonville 137
Wilmington 133
Beijing 117
Cambridge 114
New York 83
Singapore 71
Izmir 60
Shanghai 50
Nanjing 44
Princeton 40
Milan 38
Brussels 34
Addison 33
Bremen 28
Jakarta 28
Boardman 27
San Diego 25
Shenyang 19
Nanchang 17
Santa Clara 16
Changsha 13
Los Angeles 13
Tianjin 13
Brno 12
London 11
Dong Ket 9
Falls Church 8
Hebei 7
Ningbo 7
Jinan 6
Kunming 6
Redwood City 6
Jiaxing 5
Cagliari 4
Des Moines 4
Dublin 4
Hong Kong 4
Monza 4
Mountain View 4
Orange 4
Washington 4
Ardabil 3
Auburn Hills 3
Dearborn 3
Hangzhou 3
Hefei 3
Illasi 3
Norwalk 3
Philadelphia 3
Rome 3
Zhengzhou 3
Augusta 2
Bologna 2
Chongqing 2
Edinburgh 2
Guangzhou 2
Lanzhou 2
Leawood 2
Monte San Pietro 2
Palermo 2
Pasadena 2
Redmond 2
Salò 2
San Mateo 2
Toronto 2
Acton 1
Amsterdam 1
Anzola Dell'emilia 1
Berlin 1
Broomfield 1
Changchun 1
Chiswick 1
Duncan 1
Giarre 1
Hounslow 1
Johor Bahru 1
Kilburn 1
Lappeenranta 1
Melbourne 1
Monmouth Junction 1
Olomouc 1
Pescara 1
Salt Lake City 1
San Francisco 1
San Giorgio Di Piano 1
San Jose 1
Seoul 1
Simi Valley 1
Southend 1
Stockholm 1
Tallinn 1
Totale 3.469
Nome #
Chronic lymphocytic leukemia: assessing pathogenesis and prognosis by modern molecular cytogenetic studies and microRNAs expression 188
Absolute quantification of cell-free microRNAs in cancer patients 182
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 182
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 172
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 165
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 157
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 136
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 129
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 127
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 124
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 124
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 122
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 122
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 120
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 119
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 118
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 117
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 113
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 113
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 108
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 108
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 107
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 100
INTEGRATION OF NOVEL GENE MUTATIONS INTO KARYOTYPE-BASED SUBGROUPS AS A PROGNOSTIC RISK STRATIFICATION TOOL IN CHRONIC LYMPHOCYTIC LEUKEMIA 98
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 97
Quantification of Circulating miRNAs by Droplet Digital PCR: Comparison of EvaGreen- and TaqMan-Based Chemistries. 96
Refined karyotype-based prognostic stratification of chronic lymphocytic leukemia with a low- and very-low-risk genetic profile 93
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 93
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 91
EFFICACY AND SAFETY PROFILE OF DASATINIB IN A SUBSET OF VERY ELDERLY PATIENS WITH CHRONIC MYELOID LEUKEMIA (CML) RESISTANT/INTOLERANT TO IMATINIB 90
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups. 86
null 77
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 76
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 76
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 74
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 70
null 64
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome 63
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 59
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 45
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 30
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 29
Diagnostic workup for clinical and prognostic assessment of acute leukemia. 26
Additional lesions identified by genomic microarrays are associated with an inferior outcome in low-risk chronic lymphocytic leukaemia patients 7
Totale 4.493
Categoria #
all - tutte 20.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020739 0 0 36 119 71 107 87 79 91 80 42 27
2020/2021781 47 62 51 69 34 72 50 71 17 123 123 62
2021/2022539 51 36 23 25 34 23 59 30 16 36 57 149
2022/2023524 56 55 23 75 89 66 36 35 53 1 23 12
2023/2024330 22 34 9 4 17 88 22 34 7 9 5 79
2024/2025123 20 26 77 0 0 0 0 0 0 0 0 0
Totale 4.493